Prothena (PRTA)
(Real Time Quote from BATS)
$21.54 USD
-0.12 (-0.55%)
Updated Sep 20, 2024 11:18 AM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Income Statements
Fiscal Year end for Prothena Corporation plc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 91 | 54 | 201 | 1 | 1 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 91 | 54 | 201 | 1 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 282 | 185 | 129 | 114 | 87 |
Income After Depreciation & Amortization | -191 | -132 | 72 | -113 | -86 |
Non-Operating Income | 31 | 6 | 0 | 1 | 8 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -160 | -126 | 72 | -111 | -77 |
Income Taxes | -13 | -9 | 5 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -147 | -117 | 67 | -111 | -78 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -147 | -117 | 67 | -111 | -78 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -183 | -125 | 79 | -106 | -79 |
Depreciation & Amortization (Cash Flow) | 8 | 7 | 7 | 7 | 7 |
Income After Depreciation & Amortization | -191 | -132 | 72 | -113 | -86 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 53.22 | 47.37 | 48.46 | 39.92 | 39.88 |
Diluted EPS Before Non-Recurring Items | -2.76 | -2.47 | 1.38 | -2.78 | -1.95 |
Diluted Net EPS (GAAP) | -2.76 | -2.47 | 1.38 | -2.78 | -1.95 |
Fiscal Year end for Prothena Corporation plc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 132.01 | 0.05 | 0.32 | 84.87 | 4.02 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 132.01 | 0.05 | 0.32 | 84.87 | 4.02 |
SG&A, R&D, and Dept/Amort Expenses | 73.64 | 81.57 | 78.83 | 74.56 | 70.52 |
Income After SG&A, R&D, and Dept/Amort Expenses | 58.37 | -81.52 | -78.51 | 10.31 | -66.50 |
Non-Operating Income | 6.47 | 7.09 | 7.90 | 8.51 | 7.60 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 64.85 | -74.44 | -70.62 | 18.82 | -58.90 |
Income Taxes | -2.04 | -2.20 | -3.14 | -3.09 | -4.31 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 66.89 | -72.24 | -67.48 | 21.91 | -54.60 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 66.89 | -72.24 | -67.48 | 21.91 | -54.60 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 55.04 | 53.71 | 53.67 | 58.00 | 53.12 |
Diluted EPS Before Non-Recurring Items | 1.22 | -1.34 | -1.26 | 0.38 | -1.03 |
Diluted Net EPS (GAAP) | 1.22 | -1.34 | -1.22 | 0.38 | -1.03 |